RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Price:
3.66
TRY
-1.61%
Market Closed
Market Cap:
₺1.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
|
TR |
|
Apple Hospitality REIT Inc
NYSE:APLE
|
US |
|
Rhythm Biosciences Ltd
ASX:RHY
|
AU |
|
Broadstone Net Lease Inc
NYSE:BNL
|
US |
|
D
|
Daiwa Heavy Industry Co Ltd
TSE:5610
|
JP |
|
P
|
Peric Special Gases Co Ltd
SSE:688146
|
CN |
|
Saudi Arabian Cooperative Insurance Company SJSC
SAU:8100
|
SA |
|
Chongqing Sansheng Industrial Co Ltd
SZSE:002742
|
CN |
|
E
|
Eonmetall Group Bhd
KLSE:EMETALL
|
MY |
|
M
|
Matrix Design Co Ltd
SZSE:301365
|
CN |
|
Taiwan Taffeta Fabric Co Ltd
TWSE:1454
|
TW |
|
D
|
Datatec Ltd
JSE:DTC
|
ZA |
|
Sumber Global Energy Tbk PT
IDX:SGER
|
ID |
|
Kian Shen Corp
TWSE:1525
|
TW |
Multiples-Based Value
The Multiples-Based Value of one
RTALB.E
stock under the Base Case scenario is
hidden
TRY.
Compared to the current market price of 3.66 TRY,
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RTALB.E Multiples-Based Value
LOCKED
Multiples Across Competitors
RTALB.E Competitors Multiples
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Competitors
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TR |
|
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
|
1.8B TRY | 7.6 | 2.1 | 192.4 | -88.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD | 6.1 | 89.5 | 14.8 | 20.6 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD | 5.7 | 19.8 | 12.4 | 15.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.5 | 17.4 | 12.8 | 14.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD | 3.2 | 34.9 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
